Informationen:
Fehler:
ID
17301
Beschreibung
Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00600366
Link
https://clinicaltrials.gov/show/NCT00600366
Stichworte
Versionen (1)
- 05.09.16 05.09.16 -
Hochgeladen am
5. September 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Diabetes NCT00600366
Eligibility Diabetes NCT00600366
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Diabetes NCT00600366
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Insulin Therapy naive Diabetes
Item
insulin naive diabetes
boolean
C0021641 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C0011847 (UMLS CUI [1,3])
C0919936 (UMLS CUI [1,2])
C0011847 (UMLS CUI [1,3])
Oral hypoglycemic Therapeutic procedure failed secondary
Item
current treatment with oha, secondary failure
boolean
C0359086 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0205436 (UMLS CUI [1,4])
C0087111 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0205436 (UMLS CUI [1,4])
Body mass index
Item
body mass index (bmi) below 40 kg/m2
boolean
C1305855 (UMLS CUI [1])
Glycosylated hemoglobin A
Item
hba1c over 8.5%
boolean
C0019018 (UMLS CUI [1])
Insulin regime Willing | Blood Glucose Self-Monitoring Willing
Item
willing and able to start with insulin therapy and to perform self-blood glucose monitoring
boolean
C0557978 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
C0005803 (UMLS CUI [2,1])
C0600109 (UMLS CUI [2,2])
C0600109 (UMLS CUI [1,2])
C0005803 (UMLS CUI [2,1])
C0600109 (UMLS CUI [2,2])
Substance Use Disorders
Item
history of drug or alcohol abuse
boolean
C0038586 (UMLS CUI [1])
Investigational New Drugs
Item
receipt of the investigational drug within the last month prior to this trial
boolean
C0013230 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related Investigational New Drugs
Item
known or suspected allergy to trial products or related products
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
C0013230 (UMLS CUI [2,4])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
C0013230 (UMLS CUI [2,4])
Uncontrolled hypertension Severe
Item
severe uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Disease Interferes with Clinical Trial | Condition Interferes with Clinical Trial
Item
any disease or condition, which the investigator feels, would interfere with the trial
boolean
C0012634 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])